Ipek Erdogan-Trinkaus
Chief Commercial Officer · Eton Pharmaceuticals, Inc.
Individual
- 2026
- Aug 4, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ipek Erdogan-Trinkaus files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Brynjelsen - $9.91M in ETON purchases and sales in the last 12 months
- Opaleye Management Inc. - $6.89M in ETON purchases and sales in the last 12 months
- Paul V. Maier - $5.91M in ETON purchases and sales in the last 12 months
- David Krempa - $5.09M in ETON purchases and sales in the last 12 months
- Jennifer McKie Adams - $1.62M in ETON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ipek Erdogan-Trinkaus?
Ipek Erdogan-Trinkaus is a corporate insider, tracked as Chief Commercial Officer of Eton Pharmaceuticals, Inc. (ETON). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ipek Erdogan-Trinkaus submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.